» Articles » PMID: 34836115

Effect of Geumgwe-Sinkihwan on Renal Dysfunction in Ischemia/Reperfusion-Induced Acute Renal Failure Mice

Overview
Journal Nutrients
Date 2021 Nov 27
PMID 34836115
Authors
Affiliations
Soon will be listed here.
Abstract

Renal ischemia-reperfusion (I/R) injury is an important cause of acute renal failure (ARF). Geumgwe-sinkihwan (GSH) was recorded in a traditional Chines medical book named "Bangyakhappyeon" in 1884. GSH has been used for treatment for patients with diabetes and glomerulonephritis caused by deficiency of kidney yang and insufficiency of kidney gi. Here we investigate the effects of GSH in mice model of ischemic acute kidney injury. The mice groups are as follows; sham group: C57BL6 male mice, I/R group: C57BL6 male mice with I/R surgery, GSH low group: I/R + 100 mg/kg/day GSH, and GSH high group: I/R + 300 mg/kg/day GSH. Ischemia was induced by clamping both renal arteries and reperfusion. Mice were orally given GSH (100 and 300 mg/kg/day) during 3 days after surgery. Treatment with GSH significantly ameliorated creatinine clearance, creatinine, and blood urea nitrogen levels. Treatment with GSH reduced neutrophil gelatinase associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1), specific renal injury markers. GSH also reduced the periodic acid-Schiff and picro sirius red staining intensity in kidney of I/R group. Western blot and real-time RT-qPCR analysis demonstrated that GSH decreased protein and mRNA expression levels of the inflammatory cytokines in I/R-induced ARF mice. Moreover, GSH inhibited protein and mRNA expression of inflammasome-related protein including NLRP3 (NOD-like receptor pyrin domain-containing protein 3, cryoprin), ASC (Apoptosis-associated speck-like protein containing a CARD), and caspase-1. These findings provided evidence that GSH ameliorates renal injury including metabolic dysfunction and inflammation via the inhibition of NLRP3-dependent inflammasome in I/R-induced ARF mice.

References
1.
Mori K, Lee H, Rapoport D, Drexler I, Foster K, Yang J . Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115(3):610-21. PMC: 548316. DOI: 10.1172/JCI23056. View

2.
Fernandez-Llama P, Andrews P, Nielsen S, Ecelbarger C, Knepper M . Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome. Kidney Int. 1998; 53(5):1244-53. DOI: 10.1046/j.1523-1755.1998.00878.x. View

3.
Bellomo R, Kellum J, Bagshaw S . Normotensive ischemic acute renal failure. N Engl J Med. 2007; 357(21):2205. View

4.
Xiang H, Zhu F, Xu Z, Xiong J . Role of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways. Front Cell Dev Biol. 2020; 8:106. PMC: 7056742. DOI: 10.3389/fcell.2020.00106. View

5.
Moses A, Miller M, Streeten D . Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism. 1976; 25(6):697-721. DOI: 10.1016/0026-0495(76)90067-6. View